Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Study Shows How Genome Reference Bias Can Mislead Preventive Testing

By LabMedica International staff writers
Posted on 13 Oct 2026

Whole-genome sequencing is expected to play a growing role in preventive and predictive medicine, but accurate interpretation remains a major diagnostic challenge. More...

The approach requires comparing billions of DNA letters against a reference sequence to identify variants that may indicate disease susceptibility. When that reference does not adequately represent human genetic diversity, automated analysis can generate misleading findings. Addressing this limitation, new findings demonstrate how reference bias may affect preventive genomics and point to graph-based pangenomics as a potential solution.

Semmelweis University (Budapest, Hungary) researchers evaluated the limitations of GRCh38, the widely used international reference sequence for the human genome. Whole-genome sequencing reads the nearly complete genetic “text” of a person, including more than six billion DNA letters, about 40,000 genes, and regions that regulate gene function. In current workflows, automated software compares a person’s genome with the reference to flag variants that may be medically relevant.

The study, published in GeroScience, compared the whole genomes of 20 healthy Hungarians with GRCh38. In all 20 cases, automated analysis identified the same severe genetic variant. Expert curation using additional, representative regions later showed that the finding was erroneous, and none of the individuals had a true medically relevant variant. The researchers described this as an important bioinformatics vulnerability.

The issue relates to the structure of GRCh38, which is based on a single linear reference coordinate system. Although it includes genetic data from multiple individuals, 70% of the data comes from the genome of a male from Buffalo, New York. The researchers said a graph-based pan-genome could provide a richer mapping system that better reflects human genetic diversity. Such a pan-genome graph already exists, but routine clinical use has not yet been realized.

“The whole genomes of 20 healthy Hungarians were compared with the GRCh38 reference genome. In all 20 cases, the automated analysis identified the same severe genetic variant, which was later found to be erroneous following expert curation based on additional, representative regions. In other words, none of them had a true medically relevant variant. The study thus demonstrates an important bioinformatics vulnerability,” said Dr. Balázs Győrffy, head of the Department of Bioinformatics at Semmelweis University and the other lead author of the paper.

“The key question for the future is to what extent information technology will be able to keep pace with advances in medicine. Current everyday IT systems simply cannot support the daily use of such massive databases,” added Dr. Győrffy.

Related Links
Semmelweis University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers combined a blood-based biomarker of Alzheimer’s disease with age, sex, and genetic risk to estimate future cognitive impairment risk in asymptomatic adults (Image Credit: Adobe Stock)

Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk

Estimating future cognitive impairment risk remains challenging in cognitively healthy adults, particularly when biomarker findings are reduced to simple positive or negative results. Because mild cognitive... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.